SLXN
NASDAQ · Biotechnology
Silexion Therapeutics Corp
$2.66
-0.57 (-17.65%)
Analyst Consensus
Strong Buy
7
Analysts
Moderate
Coverage
Price Target
Analyst Price Target
+1,262.4% upside
Low Target
$26.81
Average Target
$36.24
High Target
$52.45
Current Price
$2.66
Current
$2.66
$2.66
Target
$36.24
$36.24
$26.81
$36.24 avg
$52.45
Scenario Analysis
Bear Case
$26.81
907.9%
Low target
Base Case
$36.24
+1,262.4%
Avg target
Bull Case
$52.45
+1,871.8%
High target
Risk/Reward
2.1x
Favorable
Price in Context
Target vs 52W High
$36.24
+11.9% vs high
Peer Consensus — Biotechnology
| Stock | Consensus | Analysts | Buy % | Target | Upside |
|---|---|---|---|---|---|
| ABBV | Strong Buy | 38 | 82% | $257.58 | -12.5% |
| AMGN | Hold | 42 | 43% | $190.87 | -59.0% |
| GILD | Strong Buy | 36 | 83% | $362.68 | +115.4% |
| VRTX | Strong Buy | 39 | 82% | $438.34 | -18.5% |
| MRNA | Hold | 31 | 32% | $149.45 | -35.4% |
| REGN | Buy | 36 | 72% | $76.80 | -91.9% |
| NTRA | Strong Buy | 31 | 90% | $142.91 | -55.7% |
| RVMD | Strong Buy | 31 | 94% | $114.11 | -35.3% |